*DISCLAIMER: These statements have not been evaluated by the Food and Drug Administration
It doesnt address the underlying causes of weight gain or promote long-term lifestyle changes necessary for healthy weight management
In pursuit of more effective obesity treatments, researchers are studying the combined use of GLP-1 with other incretin hormones (such as GIP , glucagon , and amylin ) to enhance weight reduction and cardiovascular metabolic improvements
GLP-1 injectionsincluding medications like semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda)represent a newer, evidence-based approach to medical weight loss
The early weeks of semaglutide treatment focus on adjustment, and sexual function typically recovers as GI symptoms improve
Chromosome 21 overexpression leads to alterations in genes encoding interferon receptors, proinflammatory cytokines, and oxidative stress modulators such as SOD1 71 , creating an immunometabolic environment that is both permissive to microbial imbalance and vulnerable to its consequences